\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Events

Oppenheimer 31st Annual Healthcare Conference
 March 18, 2021
 8:20am - 8:50am PDT

Dr. Mark Erlander, chief executive officer of Cardiff Oncology, will present at the Oppenheimer 31st Annual Healthcare Conference on March 18th, 2021. A replay will be available after the conclusion of the presentation and will be archived for 90 days.